UNICREDIT BANK/CALL/NOVARTIS N/105/0.1/19.03.25 Share Price

Warrant

DE000HD4FHP1

Market Closed - Bid/Ask 01:15:19 21/05/2024 am IST
0.21 EUR 0.00% Intraday chart for UNICREDIT BANK/CALL/NOVARTIS N/105/0.1/19.03.25
Current month+40.00%
1 month+110.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
21/24/21 0.21 0.00%
17/24/17 0.21 +5.00%
16/24/16 0.2 -9.09%
15/24/15 0.22 0.00%
14/24/14 0.22 +10.00%

Real-time BOERSE MUENCHEN

Last update May 21, 2024 at 01:15 am IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer UniCredit UniCredit
WKN HD4FHP
ISINDE000HD4FHP1
Date issued 08/04/2024
Strike 105 CHF
Maturity 19/03/2025 (303 Days)
Parity 10 : 1
Emission price 0.14
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.22
Lowest since issue 0.098
Spread 0.07
Spread %25.93%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
102.9 USD
Average target price
108 USD
Spread / Average Target
+4.96%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW